BEND4 Inhibitors
BEND4 inhibitors encompass a spectrum of chemical compounds that, through distinct mechanisms, lead to the downregulation of BEND4's functional activity. Staurosporine indirectly reduces BEND4 activity by general protein kinase inhibition, which may affect BEND4-related substrates and their interactions, while LY 294002 targets the PI3K/AKT pathway, potentially destabilizing BEND4's interaction with components regulated by this pathway. Rapamycin, an mTOR inhibitor, and PD 98059, a MEK1/2 inhibitor, both act by disrupting pathways that could indirectly lead to decreased BEND4 activity through the suppression of processes that involve BEND4. SB 203580 and SP600125 specifically inhibit p38 MAPK and JNK, respectively, which could affect BEND4's role in associated signaling pathways. Additionally, Ibrutinib and WZ4003, by targeting BTK and NUAK1, may inhibit BEND4 through the alteration of their respective signaling pathways.
Furthermore, the functional inhibition of BEND4 is facilitated by compounds like Triptolide and BIX-01294, which influence the transcriptional landscape that BEND4 may interact with. Triptolide diminishes NF-κB activity, potentially decreasing the expression of BEND4-regulated genes, whereas BIX-01294 affects chromatin structure and gene expression patterns associated with BEND4. Y-27632, as a ROCK inhibitor, and Thapsigargin, a SERCA pump inhibitor, act on cellular processes such as cytoskeletal dynamics and calcium homeostasis, respectively. These processes are integral to the functional context in which BEND4 operates, and their disruption leads to the indirect inhibition of BEND4, reflecting the diverse yet specific biochemical mechanisms through which these inhibitors exert their effects.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent non-selective protein kinase inhibitor that indirectly diminishes BEND4 activity by inhibiting protein kinases that phosphorylate substrates, which may interact with BEND4, thereby altering its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K which, by diminishing PI3K/AKT pathway signaling, could reduce processes that stabilize BEND4 interactions with PI3K-pathway components, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can indirectly decrease BEND4 activity through mTOR pathway inhibition, possibly affecting BEND4's interactions with proteins that are regulated by mTOR signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK1/2 which, by inhibiting the MAPK/ERK pathway, may lead to the downregulation of cellular processes that involve BEND4, resulting in its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A specific inhibitor of p38 MAPK that can diminish BEND4 activity by inhibiting p38 MAPK-mediated signaling processes that may interact with BEND4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK that could decrease BEND4's functional activity by altering JNK pathway-mediated processes in which BEND4 is implicated. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
A Bruton's tyrosine kinase inhibitor that may indirectly inhibit BEND4 by disrupting BTK-mediated signaling pathways that could stabilize BEND4 functional interactions. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
A selective NUAK1 inhibitor that may diminish BEND4 activity by altering signaling pathways involving NUAK1, potentially affecting pathways where BEND4 has a role. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
An inhibitor of the transcription factor NF-κB that could indirectly diminish BEND4 functional activity by reducing the expression of genes that interact with or regulate BEND4. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of G9a histone methyltransferase that may decrease BEND4 activity by altering chromatin structure and hence gene expression patterns that involve BEND4. | ||||||